Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening?

Authors
Wolk, A Andersson, SO Mantzoros, CS Trichopoulos, D Adami, HO
Citation
A. Wolk et al., Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening?, LANCET, 356(9245), 2000, pp. 1902-1903
Citations number
5
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
LANCET
ISSN journal
01406736 → ACNP
Volume
356
Issue
9245
Year of publication
2000
Pages
1902 - 1903
Database
ISI
SICI code
0140-6736(200012)356:9245<1902:CMOIAI>2.0.ZU;2-Y
Abstract
Further well designed studies are urgently needed to clarify If use of pros tate-specific antigen (PSA) as a diagnostic test far prostate cancer can be improved by incorporating measurements of serum insulinlike growth factor 1 (IGF-1) and insulin-like growth factor binding-protein 3 (IGFBP-3), and i f these measurements might also identify men at higher risk.